416 related articles for article (PubMed ID: 15459904)
41. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system.
Kim BJ; Chang HN; Oh DJ
Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812
[TBL] [Abstract][Full Text] [Related]
42. Hybridoma growth and antibody production as a function of cell density and specific growth rate in perfusion culture.
Banik GG; Heath CA
Biotechnol Bioeng; 1995 Nov; 48(3):289-300. PubMed ID: 18623488
[TBL] [Abstract][Full Text] [Related]
43. NS0 cell damage by high gas velocity sparging in protein-free and cholesterol-free cultures.
Zhu Y; Cuenca JV; Zhou W; Varma A
Biotechnol Bioeng; 2008 Nov; 101(4):751-60. PubMed ID: 18814288
[TBL] [Abstract][Full Text] [Related]
44. Improvement of monoclonal antibody production in hybridoma cells by dimethyl sulfoxide.
Ling WL; Deng L; Lepore J; Cutler C; Cannon-Carlson S; Wang Y; Voloch M
Biotechnol Prog; 2003; 19(1):158-62. PubMed ID: 12573019
[TBL] [Abstract][Full Text] [Related]
45. High growth rate and substrate exhaustion results in rapid cell death and lysis in the thermophilic bacterium Geobacillus thermoleovorans.
Pavlostathis SG; Marchant R; Banat IM; Ternan NG; McMullan G
Biotechnol Bioeng; 2006 Sep; 95(1):84-95. PubMed ID: 16683266
[TBL] [Abstract][Full Text] [Related]
46. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
47. A perfusion system for high productivity of monoclonal antibody by hybridoma cells in a CelliGen bioreactor.
Chen Y
Chin J Biotechnol; 1992; 8(3):179-86. PubMed ID: 1295598
[TBL] [Abstract][Full Text] [Related]
48. Cell-mass maximization in fed-batch cultures: sufficient conditions for singular arc and optimal feed rate profiles.
Shin HS; Lim HC
Bioprocess Biosyst Eng; 2006 Dec; 29(5-6):335-47. PubMed ID: 17013616
[TBL] [Abstract][Full Text] [Related]
49. Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process.
Yang JD; Angelillo Y; Chaudhry M; Goldenberg C; Goldenberg DM
Biotechnol Bioeng; 2000 Jul; 69(1):74-82. PubMed ID: 10820333
[TBL] [Abstract][Full Text] [Related]
50. Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations.
Altman SA; Randers L; Rao G
Biotechnol Prog; 1993; 9(6):671-4. PubMed ID: 7764357
[TBL] [Abstract][Full Text] [Related]
51. A fibrous-bed bioreactor for continuous production of monoclonal antibody by hybridoma.
Yang ST; Luo J; Chen C
Adv Biochem Eng Biotechnol; 2004; 87():61-96. PubMed ID: 15217104
[TBL] [Abstract][Full Text] [Related]
52. Survival factor-like activity of small peptides in hybridoma and CHO cells cultures.
Franĕk F; Fussenegger M
Biotechnol Prog; 2005; 21(1):96-8. PubMed ID: 15903245
[TBL] [Abstract][Full Text] [Related]
53. Retention and viability characteristics of mammalian cells in an acoustically driven polymer mesh.
Wang Z; Grabenstetter P; Feke DL; Belovich JM
Biotechnol Prog; 2004; 20(1):384-7. PubMed ID: 14763867
[TBL] [Abstract][Full Text] [Related]
54. Three-dimensional high-density culture of HepG2 cells in a 5-ml radial-flow bioreactor for construction of artificial liver.
Hongo T; Kajikawa M; Ishida S; Ozawa S; Ohno Y; Sawada J; Umezawa A; Ishikawa Y; Kobayashi T; Honda H
J Biosci Bioeng; 2005 Mar; 99(3):237-44. PubMed ID: 16233783
[TBL] [Abstract][Full Text] [Related]
55. Effects of elevated pCO2 and osmolality on growth of CHO cells and production of antibody-fusion protein B1: a case study.
Zhu MM; Goyal A; Rank DL; Gupta SK; Vanden Boom T; Lee SS
Biotechnol Prog; 2005; 21(1):70-7. PubMed ID: 15903242
[TBL] [Abstract][Full Text] [Related]
56. Transcriptome and proteome analysis of antibody-producing mouse myeloma NS0 cells cultivated at different cell densities in perfusion culture.
Krampe B; Swiderek H; Al-Rubeai M
Biotechnol Appl Biochem; 2008 Jul; 50(Pt 3):133-41. PubMed ID: 18302537
[TBL] [Abstract][Full Text] [Related]
57. Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures.
Henry O; Dormond E; Perrier M; Kamen A
Biotechnol Bioeng; 2004 Jun; 86(7):765-74. PubMed ID: 15162452
[TBL] [Abstract][Full Text] [Related]
58. A multifunctional bioreactor for three-dimensional cell (co)-culture.
Lichtenberg A; Dumlu G; Walles T; Maringka M; Ringes-Lichtenberg S; Ruhparwar A; Mertsching H; Haverich A
Biomaterials; 2005 Feb; 26(5):555-62. PubMed ID: 15276363
[TBL] [Abstract][Full Text] [Related]
59. Scale-up and optimization of an acoustic filter for 200 L/day perfusion of a CHO cell culture.
Gorenflo VM; Smith L; Dedinsky B; Persson B; Piret JM
Biotechnol Bioeng; 2002 Nov; 80(4):438-44. PubMed ID: 12325152
[TBL] [Abstract][Full Text] [Related]
60. Enhanced antibody production following intermediate addition based on flux analysis in mammalian cell continuous culture.
Omasa T; Furuichi K; Iemura T; Katakura Y; Kishimoto M; Suga K
Bioprocess Biosyst Eng; 2010 Jan; 33(1):117-25. PubMed ID: 19590901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
